Caricamento...
Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
Management of Graves’ orbitopathy remains an important therapeutic challenge. Current therapeutic modalities are unsatisfactory in about one third of patients. Rituximab is a monoclonal antibody against CD20 antigen that is expressed in mature and immature B cells. Early experience with rituximab su...
Salvato in:
| Pubblicato in: | Turk J Ophthalmol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Galenos Publishing
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5282540/ https://ncbi.nlm.nih.gov/pubmed/28182165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjo.26780 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|